The Impact of GLP‐1 Receptor Agonists on Esophagogastroduodenoscopy Outcomes: A Retrospective Cohort Study in a Predominantly African American Population

ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) improve glycemic control and promote weight loss but may increase gastric residue, raising concerns during esophagogastroduodenoscopy (EGD). African American patients remain underrepresented in research on these agents. Method...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ahmed El Sabagh, Ahmad Abdulraheem, Ariel Jimenez, Bara Abujaber, Usman Afzal, Ghaith Almhanni, Kiandokht Bashiri, Islam Badr Ezzeldin Mohamed, Nehal Abdelbaky, Dania Qarkash, Valeria Londono, Anna Stephan, Serenity G. Budd, Alireza Meighani
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-03-01
Series:	JGH Open
Assuntos:	African American population aspiration risk EGD endoscopy GLP‐1 receptor agonists residual gastric contents
Acceso en liña:	https://doi.org/10.1002/jgh3.70370
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!